These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 31485846)

  • 1. Management of rheumatoid arthritis: 2019 updated consensus recommendations from the Hong Kong Society of Rheumatology.
    Ho CTK; Mok CC; Cheung TT; Kwok KY; Yip RML;
    Clin Rheumatol; 2019 Dec; 38(12):3331-3350. PubMed ID: 31485846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of rheumatoid arthritis: consensus recommendations from the Hong Kong Society of Rheumatology.
    Mok CC; Tam LS; Chan TH; Lee GK; Li EK;
    Clin Rheumatol; 2011 Mar; 30(3):303-12. PubMed ID: 21046421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update of French society for rheumatology recommendations for managing rheumatoid arthritis.
    Daien C; Hua C; Gaujoux-Viala C; Cantagrel A; Dubremetz M; Dougados M; Fautrel B; Mariette X; Nayral N; Richez C; Saraux A; Thibaud G; Wendling D; Gossec L; Combe B
    Joint Bone Spine; 2019 Mar; 86(2):135-150. PubMed ID: 30315988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2018 update of the APLAR recommendations for treatment of rheumatoid arthritis.
    Lau CS; Chia F; Dans L; Harrison A; Hsieh TY; Jain R; Jung SM; Kishimoto M; Kumar A; Leong KP; Li Z; Lichauco JJ; Louthrenoo W; Luo SF; Mu R; Nash P; Ng CT; Suryana B; Wijaya LK; Yeap SS
    Int J Rheum Dis; 2019 Mar; 22(3):357-375. PubMed ID: 30809944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
    Smolen JS; Landewé RBM; Bijlsma JWJ; Burmester GR; Dougados M; Kerschbaumer A; McInnes IB; Sepriano A; van Vollenhoven RF; de Wit M; Aletaha D; Aringer M; Askling J; Balsa A; Boers M; den Broeder AA; Buch MH; Buttgereit F; Caporali R; Cardiel MH; De Cock D; Codreanu C; Cutolo M; Edwards CJ; van Eijk-Hustings Y; Emery P; Finckh A; Gossec L; Gottenberg JE; Hetland ML; Huizinga TWJ; Koloumas M; Li Z; Mariette X; Müller-Ladner U; Mysler EF; da Silva JAP; Poór G; Pope JE; Rubbert-Roth A; Ruyssen-Witrand A; Saag KG; Strangfeld A; Takeuchi T; Voshaar M; Westhovens R; van der Heijde D
    Ann Rheum Dis; 2020 Jun; 79(6):685-699. PubMed ID: 31969328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kuwait association of rheumatology 2018 treatment recommendations for patients with rheumatoid arthritis.
    Alhajeri H; Abutiban F; Al-Adsani W; Al-Awadhi A; Aldei A; AlEnizi A; Alhadhood N; Al-Herz A; Alkandari W; Dehrab A; Muhanna Ghanem AA; Hasan E; Hayat S; Saleh K; Tarakmeh H; Ali Y
    Rheumatol Int; 2019 Sep; 39(9):1483-1497. PubMed ID: 31309293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis.
    Sanmartí R; García-Rodríguez S; Álvaro-Gracia JM; Andreu JL; Balsa A; Cáliz R; Fernández-Nebro A; Ferraz-Amaro I; Gómez-Reino JJ; González-Álvaro I; Martín-Mola E; Martínez-Taboada VM; Ortiz AM; Tornero J; Marsal S; Moreno-Muelas JV
    Reumatol Clin; 2015; 11(5):279-94. PubMed ID: 26051464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
    Singh JA; Saag KG; Bridges SL; Akl EA; Bannuru RR; Sullivan MC; Vaysbrot E; McNaughton C; Osani M; Shmerling RH; Curtis JR; Furst DE; Parks D; Kavanaugh A; O'Dell J; King C; Leong A; Matteson EL; Schousboe JT; Drevlow B; Ginsberg S; Grober J; St Clair EW; Tindall E; Miller AS; McAlindon T;
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):1-25. PubMed ID: 26545825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.
    Betts KA; Griffith J; Ganguli A; Li N; Douglas K; Wu EQ
    Clin Ther; 2016 May; 38(5):1205-16. PubMed ID: 27045991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
    Louthrenoo W; Kasitanon N; Katchamart W; Aiewruengsurat D; Chevaisrakul P; Chiowchanwisawakit P; Dechanuwong P; Hanvivadhanakul P; Mahakkanukrauh A; Manavathongchai S; Muangchan C; Narongroeknawin P; Phumethum V; Siripaitoon B; Suesuwan A; Suwannaroj S; Uea-Areewongsa P; Ukritchon S; Asavatanabodee P; Koolvisoot A; Nanagara R; Totemchokchyakarn K; Nuntirooj K; Kitumnuaypong T
    Int J Rheum Dis; 2017 Sep; 20(9):1166-1184. PubMed ID: 28730640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portuguese recommendations for the use of biological and targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis - 2020 update.
    Fernandes BM; Guimarães F; Almeida DE; Neto A; Tavares-Costa J; Ribeiro AR; Quintal A; Pereira JP; Silva L; Nóvoa TSD; Faustino A; Vaz C; Khmelinskii N; Samões B; Dourado E; Silva JL; Barcelos A; Mariz E; Guerra M; Santos MJ; Silvério-António M; Teixeira RL; Romão VC; Santos H; Santos-Faria D; Azevedo S; Rodrigues A; Dias JM; Lopes C; Pinto P; Couto M; Miranda LC; Bernardo A; Cruz M; Teixeira F; Mourão AF; Neto A; Teixeira V; Cordeiro A; Barreira S; Inês LS; Capela S; Sepriano A; Canhão H; Fonseca JE; Duarte C; Bernardes M
    ARP Rheumatol; 2022; 1(1):63-82. PubMed ID: 35633578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategies are more important than drugs in the management of rheumatoid arthritis.
    Drosos AA; Pelechas E; Voulgari PV
    Clin Rheumatol; 2020 Apr; 39(4):1363-1368. PubMed ID: 32088801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.
    Nam JL; Takase-Minegishi K; Ramiro S; Chatzidionysiou K; Smolen JS; van der Heijde D; Bijlsma JW; Burmester GR; Dougados M; Scholte-Voshaar M; van Vollenhoven R; Landewé R
    Ann Rheum Dis; 2017 Jun; 76(6):1113-1136. PubMed ID: 28283512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
    Fraenkel L; Bathon JM; England BR; St Clair EW; Arayssi T; Carandang K; Deane KD; Genovese M; Huston KK; Kerr G; Kremer J; Nakamura MC; Russell LA; Singh JA; Smith BJ; Sparks JA; Venkatachalam S; Weinblatt ME; Al-Gibbawi M; Baker JF; Barbour KE; Barton JL; Cappelli L; Chamseddine F; George M; Johnson SR; Kahale L; Karam BS; Khamis AM; Navarro-Millán I; Mirza R; Schwab P; Singh N; Turgunbaev M; Turner AS; Yaacoub S; Akl EA
    Arthritis Care Res (Hoboken); 2021 Jul; 73(7):924-939. PubMed ID: 34101387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the 2012 Brazilian Society of Rheumatology Guidelines for the treatment of rheumatoid arthritis: position on the use of tofacitinib.
    da Mota LM; Cruz BA; de Albuquerque CP; Gonçalves DP; Laurindo IM; Pereira IA; de Carvalho JF; Pinheiro Gda R; Bertolo MB; Pinto MR; Louzada-Junior P; Xavier RM; Giorgi RD; Lima RA
    Rev Bras Reumatol; 2015; 55(6):512-21. PubMed ID: 26456224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis.
    Feely MG; O'Dell JR
    Curr Opin Rheumatol; 2010 May; 22(3):316-20. PubMed ID: 20190639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.
    Smolen JS; Landewé R; Breedveld FC; Dougados M; Emery P; Gaujoux-Viala C; Gorter S; Knevel R; Nam J; Schoels M; Aletaha D; Buch M; Gossec L; Huizinga T; Bijlsma JW; Burmester G; Combe B; Cutolo M; Gabay C; Gomez-Reino J; Kouloumas M; Kvien TK; Martin-Mola E; McInnes I; Pavelka K; van Riel P; Scholte M; Scott DL; Sokka T; Valesini G; van Vollenhoven R; Winthrop KL; Wong J; Zink A; van der Heijde D
    Ann Rheum Dis; 2010 Jun; 69(6):964-75. PubMed ID: 20444750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
    Fraenkel L; Bathon JM; England BR; St Clair EW; Arayssi T; Carandang K; Deane KD; Genovese M; Huston KK; Kerr G; Kremer J; Nakamura MC; Russell LA; Singh JA; Smith BJ; Sparks JA; Venkatachalam S; Weinblatt ME; Al-Gibbawi M; Baker JF; Barbour KE; Barton JL; Cappelli L; Chamseddine F; George M; Johnson SR; Kahale L; Karam BS; Khamis AM; Navarro-Millán I; Mirza R; Schwab P; Singh N; Turgunbaev M; Turner AS; Yaacoub S; Akl EA
    Arthritis Rheumatol; 2021 Jul; 73(7):1108-1123. PubMed ID: 34101376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendations.
    Harrold LR; Reed GW; Kremer JM; Curtis JR; Solomon DH; Hochberg MC; Kavanaugh A; Saunders KC; Shan Y; Spruill TM; Pappas DA; Greenberg JD
    Arthritis Res Ther; 2016 Apr; 18():94. PubMed ID: 27118040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.